Rights and permissions
About this article
Cite this article
Erlotinib plus gemcitabine prolongs survival in pancreatic cancer. Inpharma Wkly. 1458, 6 (2004). https://doi.org/10.2165/00128413-200414580-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414580-00010